IntoCell인투셀
287840 · KOSDAQ · ₩287840 · 인투셀
₩15,980▼ ₩120 (0.75%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩2.3B | ₩2.9B |
| Operating income | −₩10B | −₩9.8B |
| Net income | −₩11B | −₩9.9B |
| Net income to shareholders | −₩11B | −₩9.9B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩41B | ₩24B |
| Current assets | ₩31B | ₩13B |
| Cash and equivalents | ₩12B | ₩7B |
| Total liabilities | ₩17B | ₩16B |
| Current liabilities | ₩3.2B | ₩14B |
| Borrowings | ₩10B | ₩10B |
| Total equity | ₩25B | ₩7.5B |
| Shareholders' equity | ₩25B | ₩7.5B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | −₩8.6B | −₩7B |
| Capital spending | ₩143M | ₩71M |
| Free cash flow | −₩8.8B | −₩7.1B |
Consolidated where available. Amounts in won.
Also known as: IntoCell / 인투셀 / 287840 / KRX:287840
Source: KRX statistical information